Status:
RECRUITING
Determination of the Minimal Detectable Change of the Parkinson's Disease Questionnaire-8
Lead Sponsor:
Emre Şenocak
Conditions:
Parkinson Disease
Eligibility:
All Genders
40-80 years
Brief Summary
This study is conducted to determine how many units of improvement the Parkinson's Disease Questionnaire-8 (PDQ-8), used to evaluate the quality of life of Parkinson's patients, should have to express...
Eligibility Criteria
Inclusion
- Having regular neurology follow-up and using medicine;
- Hoehn and Yahr Scale Stage between 1-3 points;
- Mini-Mental State Assessment Score \>24 points;
Exclusion
- Having a secondary neurological disease;
- Any surgery and/or trauma affecting the upper extremity
- Having complaints of pain before the treatment program;
- There was a change in medical treatment during the study;
- With symptoms of anxiety and depression;
- Those who use alcohol and drugs;
- Individuals with vision defects that cannot be corrected by the use of glasses and those with hearing loss
Key Trial Info
Start Date :
May 13 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 17 2025
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT06487364
Start Date
May 13 2024
End Date
September 17 2025
Last Update
March 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Private Güney Hospital
Istanbul, Turkey (Türkiye), 34230